152 results on '"Pandey, Ambarish"'
Search Results
2. Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis
3. Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA
4. Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis
5. Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial Infarction
6. Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
7. Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF
8. Association of Beta-Blocker Use With Exercise Capacity in Participants With Heart Failure With Preserved Ejection Fraction: A Post Hoc Analysis of the RELAX Trial
9. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
10. National Variation in Hospital MTEER Outcomes and Correlation With TAVR Outcomes: STS/ACC TVT Registry Analysis
11. Associations Between Cardiac Function and Brain Health in Diverse Middle-Aged Adults: The Dallas Heart Study-2
12. Role of exercise therapy and cardiac rehabilitation in heart failure
13. Managing Obesity in Heart Failure: A Chance to Tip the Scales?
14. Incident Heart Failure Risk Reclassification With Race-Independent Estimated Glomerular Filtration Rate: A National Heart, Lung, and Blood Institute Pooled Cohorts Analysis
15. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial
16. Racial differences in low natriuretic peptide levels: Implications for heart failure clinical trials
17. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America
18. Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease: JACC Scientific Statement
19. Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With Reduced Ejection Fraction
20. Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction
21. Neighborhood-level Social Vulnerability and Prevalence of Cardiovascular Risk Factors and Coronary Heart Disease
22. Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society
23. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
24. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society
25. Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials
26. Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults
27. Exercise Training, Cardiac Biomarkers, and Cardiorespiratory Fitness in Type 2 Diabetes: The HART-D Study
28. Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA)
29. Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019
30. Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study
31. Supranormal Left Ventricular Ejection Fraction, Stroke Volume, and Cardiovascular Risk: Findings From Population-Based Cohort Studies
32. Association Between Thigh Muscle Fat Infiltration and Incident Heart Failure: The Health ABC Study
33. The Relationship Between Atrial Fibrillation, Mitral Regurgitation, and Heart Failure Subtype: The ARIC Study
34. Mid-Life Cardiorespiratory Fitness, Obesity, and Risk of Atrial Fibrillation: The Cooper Center Longitudinal Study
35. Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018
36. Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population
37. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial
38. Association of readmission penalty amount with subsequent 30-day risk standardized readmission and mortality rates among patients hospitalized with heart failure: An analysis of get with the guidelines – heart failure participating centers
39. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population
40. Guideline based eligibility for primary prevention statin therapy – Insights from the North India ST-elevation myocardial infarction registry (NORIN-STEMI)
41. Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults
42. Risk-Adjusted, 30-Day Home Time After Transcatheter Aortic Valve Replacement as a Hospital-Level Performance Metric
43. Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018
44. Patient characteristics, care patterns, and outcomes of atrial fibrillation associated hospitalizations in patients with chronic kidney disease and end-stage renal disease
45. Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
46. Association of COVID-19 Hospitalization Volume and Case Growth at US Hospitals with Patient Outcomes
47. Clinical and Echocardiographic Characteristics of Patients Hospitalized With Acute Versus Chronic Heart Failure With Preserved Ejection Fraction (From the ARIC Study)
48. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
49. Deep-Learning Models for the Echocardiographic Assessment of Diastolic Dysfunction
50. Hospitalizations and Outcomes of T1MI Observed Before and After the Introduction of MI Subtype Codes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.